A Randomized, Controlled Study in Preterm Neonates With RDS to Compare Two Procedures for Porcine Surfactant (Poractant Alfa, CUROSURF®) Administration: a Less Invasive Method (LISA) and the Conventional Administration
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 19 Jan 2017
At a glance
- Drugs Poractant alfa (Primary)
- Indications Neonatal respiratory distress syndrome
- Focus Adverse reactions
- Acronyms LISPAP
- Sponsors Chiesi Farmaceutici SpA
- 12 Jan 2017 Planned End Date changed from 1 Dec 2020 to 1 Dec 2021.
- 12 Jan 2017 Planned primary completion date changed from 1 Apr 2018 to 1 Oct 2019.
- 12 Jan 2017 Planned initiation date changed from 1 Nov 2016 to 1 Jun 2018.